Tarsus Pharmaceuticals
TARS
TARS
203 hedge funds and large institutions have $1.87B invested in Tarsus Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 85 increasing their positions, 50 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
+12
Holders Change %
+6.28%
% of All Funds
2.72%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.05%
New
44
Increased
85
Reduced
50
Closed
29
Calls
$417K
Puts
–
Net Calls
+$417K
Net Calls Change
-$347K
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$52.4M |
| 2 |
BlackRock
New York
|
+$25.9M |
| 3 |
ClearBridge Investments
New York
|
+$18M |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$14.8M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$13.8M |
Top Sellers
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$35.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$30.9M |
| 3 |
O
OrbiMed
New York
|
-$18.5M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$13.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$13.6M |
